Prendergast GC - Search Results

1

Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.

Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM. Kutner T, et al. Among authors: prendergast gc. Support Care Cancer. 2017 Feb;25(2):581-587. doi: 10.1007/s00520-016-3442-5. Epub 2016 Oct 12. Support Care Cancer. 2017. PMID: 27734152

2

Tissue inhibitor of metalloproteinase-4 is elevated in early-stage breast cancers with accelerated progression and poor clinical course.

Liss M, Sreedhar N, Keshgegian A, Sauter G, Chernick MR, Prendergast GC, Wallon UM. Liss M, et al. Among authors: prendergast gc. Am J Pathol. 2009 Sep;175(3):940-6. doi: 10.2353/ajpath.2009.081094. Epub 2009 Aug 21. Am J Pathol. 2009. PMID: 19700750 Free PMC article.

3

Development of a monoclonal antibody that specifically detects tissue inhibitor of metalloproteinase-4 (TIMP-4) in formalin-fixed, paraffin-embedded human tissues.

Donover PS, Wojciechowski BS, Thirumaran R, Zemba-Palko V, Prendergast GC, Wallon UM. Donover PS, et al. Among authors: prendergast gc. J Cell Biochem. 2010 Aug 1;110(5):1255-61. doi: 10.1002/jcb.22641. J Cell Biochem. 2010. PMID: 20564221

4

Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer.

Fox E, Oliver T, Rowe M, Thomas S, Zakharia Y, Gilman PB, Muller AJ, Prendergast GC. Fox E, et al. Among authors: prendergast gc. Front Oncol. 2018 Sep 11;8:370. doi: 10.3389/fonc.2018.00370. eCollection 2018. Front Oncol. 2018. PMID: 30254983 Free PMC article. Review.

5

Marrying immunotherapy with chemotherapy: why say IDO?

Muller AJ, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Cancer Res. 2005 Sep 15;65(18):8065-8. doi: 10.1158/0008-5472.CAN-05-2213. Cancer Res. 2005. PMID: 16166276 Review.

6

Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.

Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ, Prendergast GC. Chang MY, et al. Among authors: prendergast gc. Cancer Res. 2007 Jan 1;67(1):100-7. doi: 10.1158/0008-5472.CAN-06-2742. Cancer Res. 2007. PMID: 17210688

7

Discovery of IDO1 Inhibitors: From Bench to Bedside.

Prendergast GC, Malachowski WP, DuHadaway JB, Muller AJ. Prendergast GC, et al. Cancer Res. 2017 Dec 15;77(24):6795-6811. doi: 10.1158/0008-5472.CAN-17-2285. Cancer Res. 2017. PMID: 29247038 Free PMC article. Review.

8

Cancer immunologists and cancer biologists: why we didn't talk then but need to now.

Prendergast GC, Jaffee EM. Prendergast GC, et al. Cancer Res. 2007 Apr 15;67(8):3500-4. doi: 10.1158/0008-5472.CAN-06-4626. Epub 2007 Apr 5. Cancer Res. 2007. PMID: 17413003

9

Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.

Muller AJ, DuHadaway JB, Jaller D, Curtis P, Metz R, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Cancer Res. 2010 Mar 1;70(5):1845-53. doi: 10.1158/0008-5472.CAN-09-3613. Epub 2010 Feb 16. Cancer Res. 2010. PMID: 20160032 Free PMC article.

10

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.

Muller AJ, Manfredi MG, Zakharia Y, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Semin Immunopathol. 2019 Jan;41(1):41-48. doi: 10.1007/s00281-018-0702-0. Epub 2018 Sep 10. Semin Immunopathol. 2019. PMID: 30203227 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters